Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor- resistant mutants

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9024-9031

  Saeki, Keiichi ^a   Ohtsuka, Nobuhisa ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR PROTEIN; SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS MUTANT; VIRUS NEUTRALIZATION;

EID: 0030780569     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9024-9031.1997     Document Type: Article

References (49)

1. Chen, D. S., M. Asanaka, K. Yokomori, F. Wang, S. B. Hwang, H. Li, and M. M. C. Lai. 1995. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA 92:12095-12099.
2. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
3. Collins, A. R., R. L. Knobler, H. Powell, and M. J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell fusion. Virology 119:358-371.
4. Colston, E., and V. R. Racaniello. 1994. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 13:5855-5862.
5. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463-471.
6. De Groot, R. J., W. Luytjes, M. C. Horzinek, B. A. M. Van der Zeijst, W. J. M. Spaan, and J. A. Lenstra. 1987. Evidence for a coiled-coil structure in the spike of coronaviruses. J. Mol. Biol. 196:963-966.
7. Dunning, A. M., P. Talmud, and S. E. Humphries. 1988. Errors in the polymerase chain reaction. Nucleic Acids Res. 16:10393.
8. Dveksler, G. S., C. W. Diffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G. S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1-8.
9. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. Jiang, K. V. Holmes, and C. W. Diffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
10. Dveksler, G. S., M. N. Pensiero, C. W. Diffenbach, C. B. Cardeilichio, A. A. Basile, P. E. Elia, and K. V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
11. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated and has a reduced rate of spread in the central nervous system. Virology 187:178-188.
12. Fleming, J. O., M. D. Trousdale, F. A. K. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869-875.
13. Flory, E., M. Pfleiderer, A. Stuhler, and H. Wege. 1993. Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo. Eur. J. Immunol. 23:1757-1761.
14. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
15. Fuerst, T. R., P. L. Earl, and B. Moss. 1987. Use of hybrid vaccinia virus-T7 RNA polymerase system for the expression of target genes. Mol. Cell. Biol. 7:2538-2544.
16. Gallagher, T. M. 1996. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:4683-4690.
17. Gallagher, T. M. 1997. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:3129-3137.
18. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
19. Grosse, B., and S. G. Siddell. 1994. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1-specific monoclonal antibody. Virology 202:814-824.
20. Hirano, N., K. Fujiwara, S. Hino, and M. Matsumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
21. Holmes, K. V., E. W. Doller, and J. N. Behnke. 1981. Analysis of the function of coronavirus glycoprotein by differential inhibition of synthesis with tunicamycin. Adv. Exp. Med. Biol. 142:133-142.
22. Kaplan, G., D. Peters, and V. R. Racaniello. 1990. Poliovirus mutants resistant to neutralization with soluble cell receptors. Science 250:1596-1599.
23. Kubo, H., S. Y. Takase, and F. Taguchi. 1993. Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV cl-2 variant. J. Gen. Virol. 74:1421-1425.
24. Kubo, H., Y. K. Yamada, and F. Taguchi. 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:5403-5410.
25. Kyuwa, S., and S. A. Stohlman. 1990. Pathogenesis of a neurotropic murine coronavirus strain, JHM, in the central nervous system of mice. Semin. Virol. 1:273-280.
26. Lai, M. M. C. 1990. Coronaviruses: organization, replication and expression of genome. Annu. Rev. Microbiol. 44:303-333.
27. Matsubara, Y., R. Watanabe, and F. Taguchi. 1991. Neurovirulence of six different murine coronavirus JHMV variants for rats. Virus Res. 20:45-58.
28. McCuaig, K., M. Rosenberg, P. Nedellec, C. Turbide, and N. Beauchemin. 1993. Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. Gene 127:173-183.
29. Nedellec, P., G. S. Dveksler, E. Daniels, E. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
30. Ohtsuka, N., Y. K. Yamada, and F. Taguchi. 1996. Difference in virus-binding activity of two distinct receptor proteins for mouse hepatitis virus. J. Gen. Virol. 77:1683-1692.
31. Routledge, E., R. Stauber, M. Pfleiderer, and S. G. Siddell. 1991. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J. Virol. 65:254-262.
32. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
33. Siddell, S. G. 1995. The coronaviridae, an introduction, p. 1-10. In S. G. Siddell (ed.), Coronaviridae. Plenum Press, New York, N.Y.
34. Spaan, W., D. Cavanagh, and M. C. Horzinek. 1988. Coronaviruses: structure and genome expression. J. Gen. Virol. 69:2939-2952.
35. Stauber, R., M. Pfleiderer, and S. Siddell. 1993. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J. Gen. Virol. 74:183-191.
36. Sturman, L. S., and K. V. Holmes. 1984. Proteolytic cleavage of peplomer glycoprotein E2 of MHV yields two 90 K subunits and activates cell fusion. Adv. Exp. Med. Biol. 173:25-35.
37. Suzuki, H., and F. Taguchi. 1996. Analysis of the receptor binding site of murine coronavirus spike glycoprotein. J. Virol. 70:2632-2636.
38. Taguchi, F. 1993. Fusion formation by uncleaved spike protein of murine coronavirus JHMV variant cl-2. J. Virol. 67:1195-1202.
39. Taguchi, F. 1995. The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J. Virol. 69:7260-7263.
40. Taguchi, F., and J. O. Fleming. 1989. Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology 169:233-235.
41. Taguchi, F., T. Ikeda, and H. Shida. 1992. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73:1065-1072.
42. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen. 1985. Characterization of a variant virus selected in rat brain after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:429-435.
43. Taguchi, F., A. Yamada, and K. Fujiwara. 1980. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect. Immun. 29:42-49.
44. Vennema, H., L. Hejnen, A. Zijderfeld, M. C. Horziek, and W. J. M. Spaan. 1990. Intracellular transport of recombinant coronavirus spike proteins: implication for virus assembly. J. Virol. 64:339-346.
45. Wang, F.-I., J. O. Fleming, and M. M. C. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic site affecting neuropathogenicity. Virology 186:742-749.
46. Wege, H., S. G. Siddell, and V. ter Meulen. 1982. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 99:165-200.
47. White, J. M. 1990. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:675-697.
48. Williams, R. K., G. S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
49. Yamada, Y. K., K. Takimoto, M. Yabe, and F. Taguchi. 1997. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology 227:215-219.